Inactivation of the Glucose-Dependent Insulinotropic Polypeptide Receptor Improves Outcomes following Experimental Myocardial Infarction.

Published

Journal Article

Incretin hormones exert pleiotropic metabolic actions beyond the pancreas. Although the heart expresses both incretin receptors, the cardiac biology of GIP receptor (GIPR) action remains incompletely understood. Here we show that GIPR agonism did not impair the response to cardiac ischemia. In contrast, genetic elimination of the Gipr reduced myocardial infarction (MI)-induced ventricular injury and enhanced survival associated with reduced hormone sensitive lipase (HSL) phosphorylation; it also increased myocardial triacylglycerol (TAG) stores. Conversely, direct GIPR agonism in the isolated heart reduced myocardial TAG stores and increased fatty acid oxidation. The cardioprotective phenotype in Gipr-/- mice was partially reversed by pharmacological activation or genetic overexpression of HSL. Selective Gipr inactivation in cardiomyocytes phenocopied Gipr-/- mice, resulting in improved survival and reduced adverse remodeling following experimental MI. Hence, the cardiomyocyte GIPR regulates fatty acid metabolism and the adaptive response to ischemic cardiac injury. These findings have translational relevance for developing GIPR-based therapeutics.

Full Text

Duke Authors

Cited Authors

  • Ussher, JR; Campbell, JE; Mulvihill, EE; Baggio, LL; Bates, HE; McLean, BA; Gopal, K; Capozzi, M; Yusta, B; Cao, X; Ali, S; Kim, M; Kabir, MG; Seino, Y; Suzuki, J; Drucker, DJ

Published Date

  • February 6, 2018

Published In

Volume / Issue

  • 27 / 2

Start / End Page

  • 450 - 460.e6

PubMed ID

  • 29275960

Pubmed Central ID

  • 29275960

Electronic International Standard Serial Number (EISSN)

  • 1932-7420

Digital Object Identifier (DOI)

  • 10.1016/j.cmet.2017.11.003

Language

  • eng

Conference Location

  • United States